...BRCA2 gene mutations confirmed earlier results showing clinical benefit for advanced breast and ovarian cancers, and dem...
...BRCA2 mutations.,We studied 454 BRCA1 and 273 BRCA2 mutation carriers ages younger than 50 years from three breast cance...
...BRCA2 carriers. We report the genetic evaluation of seven cases with suspected RAS from patients counseled in our cancer...
...BRCA2 (deficient in homologous recombination repair) than in parental cells; this indicates that the induction of DNA da...
...BRCA2; this raises the possibility that germline PALB2 mutations may be involved in the pathogenesis of TNBCs. In our st...
...BRCA2 are responsible for a large proportion of familial breast cancer cases, and therefore, BRCA1 and BRCA2 genetic tes...
...BRCA2-associated, and 242 familial non-BRCA1/2 cancers) were studied. Each tumor had a centralized pathology review perf...
...BRCA2 and CHEK2. The aim of this study was to examine the allele and genotype frequencies of seven mutations in BRCA1, B...
There is a significant variation in the uptake of cancer risk reducing options by women with a BRCA1 or BRCA2 mutation. ...
...BRCA2 mutation affects the survival of women with breast cancer and prognostic factors among BRCA2-positive women warran...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
